First Manhattan’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,079
| Closed | -$5K | – | 1635 |
|
|
2021
Q3 | $5K | Hold |
1,079
| – | – | ﹤0.01% | 1390 |
|
|
2021
Q2 | $4K | Buy |
+1,079
| New | +$4K | ﹤0.01% | 1434 |
|
|
2019
Q3 | – | Sell |
-2,949,979
| Closed | -$18.6M | – | 1373 |
|
|
2019
Q2 | $18.6M | Buy |
2,949,979
+201,393
| +7% | +$1.27M | 0.1% | 115 |
|
|
2019
Q1 | $15.3M | Buy |
+2,748,586
| New | +$15.3M | 0.09% | 125 |
|
|
2018
Q2 | – | Sell |
-5,000
| Closed | -$42K | – | 1397 |
|
|
2018
Q1 | $42K | Hold |
5,000
| – | – | ﹤0.01% | 982 |
|
|
2017
Q4 | $49K | Hold |
5,000
| – | – | ﹤0.01% | 1007 |
|
|
2017
Q3 | $61K | Hold |
5,000
| – | – | ﹤0.01% | 914 |
|
|
2017
Q2 | $82K | Buy |
+5,000
| New | +$82K | ﹤0.01% | 845 |
|
|
2014
Q4 | – | Sell |
-41
| Closed | – | – | 1506 |
|
|
2014
Q3 | $0 | Buy |
+41
| New | – | ﹤0.01% | 1460 |
|